Theresa Whiteside

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Szczepanski Miroslaw J; Szajnik Marta; Welsh Ann; Foon Kenneth A; Whiteside Theresa L; Boyiadzis Michael
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
Ge Lisheng; Baskic Dejan; Basse Per; Vujanovic Lazar; Unlu Sebnem; Yoneyama Toshie; Vujanovic Andrea; Han Jie; Bankovic Dragic; Szczepanski Miroslaw J; Hunt Jennifer L; Herberman Ronald B; Gollin Susanne M; Ferris Robert L; Whiteside Theresa L; Myers Eugene N; Vujanovic Nikola L
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.
Whiteside Theresa L
Tricks tumors use to escape from immune control.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Theresa Whiteside (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Szczepanski Miroslaw J; Szajnik Marta; Welsh Ann; Foon Kenneth A; Whiteside Theresa L; Boyiadzis Michael
Interleukin-15 enhances natural killer cell cytotoxicity in patients with acute myeloid leukemia by upregulating the activating NK cell receptors.
Cancer immunology, immunotherapy : CII 2010;59(1):73-9.
2009: Ge Lisheng; Baskic Dejan; Basse Per; Vujanovic Lazar; Unlu Sebnem; Yoneyama Toshie; Vujanovic Andrea; Han Jie; Bankovic Dragic; Szczepanski Miroslaw J; Hunt Jennifer L; Herberman Ronald B; Gollin Susanne M; Ferris Robert L; Whiteside Theresa L; Myers Eugene N; Vujanovic Nikola L
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(11):2913-22.
2009: Whiteside Theresa L
Tricks tumors use to escape from immune control.
Oral oncology 2009;45(10):e119-23.
2009: Wieckowski Eva U; Visus Carmen; Szajnik Marta; Szczepanski Miroslaw J; Storkus Walter J; Whiteside Theresa L
Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(6):3720-30.
2009: Chikamatsu Kazuaki; Sakakura Koichi; Takahashi Goro; Okamoto Atsushi; Furuya Nobuhiko; Whiteside Theresa L; DeLeo Albert B; Masuyama Keisuke
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
Cancer immunology, immunotherapy : CII 2009;58(9):1441-8.
2009: Mandapathil Magis; Lang Stephan; Gorelik Elieser; Whiteside Theresa L
Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expression.
Journal of immunological methods 2009;346(1-2):55-63.
2009: Albers Andreas E; Schaefer Carsten; Visus Carmen; Gooding William; DeLeo Albert B; Whiteside Theresa L
Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer.
Head & neck 2009;31(6):773-81.
2009: Hoffmann Thomas K; Schirlau Kerstin; Sonkoly Enikö; Brandau Sven; Lang Stephan; Pivarcsi Andor; Balz Vera; Müller Anja; Homey Bernhard; Boelke Edwin; Reichert Torsten; Friebe-Hoffmann Ulrike; Greve Jens; Schuler Patrick; Scheckenbach Kathrin; Schipper Jörg; Bas Murat; Whiteside Theresa L; Bier Henning
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration.
International journal of cancer. Journal international du cancer 2009;124(11):2589-96.
2009: Szczepanski Miroslaw J; Szajnik Marta; Czystowska Malgorzata; Mandapathil Magis; Strauss Laura; Welsh Ann; Foon Kenneth A; Whiteside Theresa L; Boyiadzis Michael
Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(10):3325-32.
2009: Czystowska M; Han J; Szczepanski M J; Szajnik M; Quadrini K; Brandwein H; Hadden J W; Signorelli K; Whiteside T L
IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death.
Cell death and differentiation 2009;16(5):708-18.
2009: Szczepanski Miroslaw J; Czystowska Malgorzata; Szajnik Marta; Harasymczuk Malgorzata; Boyiadzis Michael; Kruk-Zagajewska Aleksandra; Szyfter Witold; Zeromski Jan; Whiteside Theresa L
Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
Cancer research 2009;69(7):3105-13.
2009: Bergmann Christoph; Strauss Laura; Wieckowski Eva; Czystowska Malgorzata; Albers Andreas; Wang Yun; Zeidler Reinhard; Lang Stephan; Whiteside Theresa L
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progression.
Head & neck 2009;31(3):371-80.
2009: Strauss Laura; Bergmann Christoph; Whiteside Theresa L
Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(3):1469-80.
2009: Whiteside Theresa L; Piazza Paolo; Reiter Amanda; Stanson Joanna; Connolly Nancy C; Rinaldo Charles R; Riddler Sharon A
Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
Clinical and vaccine immunology : CVI 2009;16(2):233-40.
2009: Vujanovic Lazar; Whiteside Theresa L; Potter Douglas M; Chu Jessica; Ferrone Soldano; Butterfield Lisa H
Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus.
Cancer immunology, immunotherapy : CII 2009;58(1):121-33.
2009: Strauss Laura; Czystowska Malgorzata; Szajnik Marta; Mandapathil Magis; Whiteside Theresa L
Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
PloS one 2009;4(6):e5994.
2008: Hoffmann Thomas K; Sonkoly Eniko; Hauser Ulrich; van Lierop Anke; Whiteside Theresa L; Klussmann Jens Peter; Hafner Dieter; Schuler Patrick; Friebe-Hoffmann Ulrike; Scheckenbach Kathrin; Erjala Kaisa; Grénman Reidar; Schipper Jörg; Bier Henning; Balz Vera
Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma.
Oral oncology 2008;44(12):1100-9.
2008: Whiteside T L
The tumor microenvironment and its role in promoting tumor growth.
Oncogene 2008;27(45):5904-12.
2008: DeLeo Albert B; Whiteside Theresa L
Development of multi-epitope vaccines targeting wild-type sequence p53 peptides.
Expert review of vaccines 2008;7(7):1031-40.
2008: Chikamatsu Kazuaki; Sakakura Koichi; Yamamoto Takanori; Furuya Nobuhiko; Whiteside Theresa L; Masuyama Keisuke
CD4+ T helper responses in squamous cell carcinoma of the head and neck.
Oral oncology 2008;44(9):870-7.
2008: Bergmann Christoph; Strauss Laura; Wang Yun; Szczepanski Miroslaw J; Lang Stephan; Johnson Jonas T; Whiteside Theresa L
T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3706-15.
2008: Strauss Laura; Bergmann Christoph; Szczepanski Miroslaw J; Lang Stephan; Kirkwood John M; Whiteside Theresa L
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(5):2967-80.
2008: Connolly Nancy C; Whiteside Theresa L; Wilson Cara; Kondragunta Venkatswarlu; Rinaldo Charles R; Riddler Sharon A
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
Clinical and vaccine immunology : CVI 2008;15(2):284-92.
2008: Butterfield Lisa H; Gooding William; Whiteside Theresa L
Development of a potency assay for human dendritic cells: IL-12p70 production.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):89-100.
2008: Whiteside Theresa L
Immune monitoring of clinical trials with biotherapies.
Advances in clinical chemistry 2008;45():75-97.
2007: Strauss Laura; Bergmann Christoph; Whiteside Theresa L
Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
International journal of cancer. Journal international du cancer 2007;121(11):2473-83.
2007: Whiteside Theresa L
Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor.
Current cancer drug targets 2007;7(7):633-42.
2007: Strauss Laura; Bergmann Christoph; Gooding William; Johnson Jonas T; Whiteside Theresa L
The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6301-11.
2007: Visus Carmen; Ito Diasuke; Amoscato Andrew; Maciejewska-Franczak Malgorzata; Abdelsalem Ahmed; Dhir Rajiv; Shin Dong M; Donnenberg Vera S; Whiteside Theresa L; DeLeo Albert B
Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
Cancer research 2007;67(21):10538-45.
2007: Ferrone Soldano; Whiteside Theresa L
Tumor microenvironment and immune escape.
Surgical oncology clinics of North America 2007;16(4):755-74, viii.
2007: Bergmann Christoph; Strauss Laura; Zeidler Reinhard; Lang Stephan; Whiteside Theresa L
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Cancer research 2007;67(18):8865-73.
2007: Bergmann Christoph; Strauss Laura; Zeidler Reinhard; Lang Stephan; Whiteside Theresa L
Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment.
Cancer immunology, immunotherapy : CII 2007;56(9):1429-42.
2007: Connolly Nancy; Riddler Sharon; Stanson Joanna; Gooding William; Rinaldo Charles R; Ferrone Soldano; Whiteside Theresa L
Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects.
AIDS (London, England) 2007;21(13):1683-92.
2007: Strauss Laura; Bergmann Christoph; Szczepanski Miroslaw; Gooding William; Johnson Jonas T; Whiteside Theresa L
A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(15 Pt 1):4345-54.
2007: Kim G G; Donnenberg V S; Donnenberg A D; Gooding W; Whiteside T L
A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Journal of immunological methods 2007;325(1-2):51-66.
2007: Ito Daisuke; Visus Carmen; Hoffmann Thomas K; Balz Vera; Bier Henning; Appella Ettore; Whiteside Theresa L; Ferris Robert L; DeLeo Albert B
Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 2007;120(12):2618-24.
2007: Hoffmann Thomas K; Sonkoly Eniko; Homey Bernhard; Scheckenbach Katrin; Gwosdz Christian; Bas Murat; Chaker Adam; Schirlau Kerstin; Whiteside Theresa L
Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
Head & neck 2007;29(5):472-8.
2007: Lin Charles J; Grandis Jennifer R; Carey Thomas E; Gollin Susanne M; Whiteside Theresa L; Koch Wayne M; Ferris Robert L; Lai Stephen Y
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.
Head & neck 2007;29(2):163-88.
2007: Cyranowski Jill M; Marsland Anna L; Bromberger Joyce T; Whiteside Theresa L; Chang Yuefang; Matthews Karen A
Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro.
Brain, behavior, and immunity 2007;21(2):229-37.
2007: Wieckowski Eva; Atarashi Yoshinari; Stanson Joanna; Sato Taka-Aki; Whiteside Theresa L
FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
Journal of cellular biochemistry 2007;100(1):16-28.
2007: Ueda Ryo; Low Keri L; Zhu Xinmei; Fujita Mitsugu; Sasaki Kotaro; Whiteside Theresa L; Butterfield Lisa H; Okada Hideho
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.
Journal of translational medicine 2007;5():68.
2007: Okada Hideho; Lieberman Frank S; Walter Kevin A; Lunsford L Dade; Kondziolka Douglas S; Bejjani Ghassan K; Hamilton Ronald L; Torres-Trejo Alejandro; Kalinski Pawel; Cai Quan; Mabold Jennifer L; Edington Howard D; Butterfield Lisa H; Whiteside Theresa L; Potter Douglas M; Schold S Clifford; Pollack Ian F
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas.
Journal of translational medicine 2007;5():67.
2007: Whiteside Theresa L
The role of death receptor ligands in shaping tumor microenvironment.
Immunological investigations 2007;36(1):25-46.
2006: Artusio Elisa; Hathaway Bridget; Stanson Joanna; Whiteside Theresa L
Transfection of human monocyte-derived dendritic cells with native tumor DNA induces antigen-specific T-cell responses in vitro.
Cancer biology & therapy 2006;5(12):1624-31.
2006: Ito Daisuke; Albers Andreas; Zhao Yong Xiang; Visus Carmen; Appella Ettore; Whiteside Theresa L; DeLeo Albert B
The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(10):6795-803.
2006: Bas Murat; Bier Henning; Schirlau Kerstin; Friebe-Hoffmann Ulrike; Scheckenbach Kathrin; Balz Vera; Whiteside Theresa L; Hoffmann Thomas K
Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Oral oncology 2006;42(7):691-7.
2006: Ferris Robert L; Whiteside Theresa L; Ferrone Soldano
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(13):3890-5.
2006: Muller Anja; Sonkoly Eniko; Eulert Christine; Gerber Peter Arne; Kubitza Robert; Schirlau Kerstin; Franken-Kunkel Petra; Poremba Christopher; Snyderman Carl; Klotz Lars-Oliver; Ruzicka Thomas; Bier Henning; Zlotnik Albert; Whiteside Theresa L; Homey Bernhard; Hoffmann Thomas K
Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy.
International journal of cancer. Journal international du cancer 2006;118(9):2147-57.
2006: Albers Andreas E; Visus Carmen; Tsukishiro Takashi; Ferris Robert L; Gooding William; Whiteside Theresa L; De Leo Albert B
Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(8):2394-403.
2006: Hoffmann Thomas K; Arsov Christian; Schirlau Kerstin; Bas Murat; Friebe-Hoffmann Ulrike; Klussmann Jens Peter; Scheckenbach Kathrin; Balz Vera; Bier Henning; Whiteside Theresa L
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx.
International journal of cancer. Journal international du cancer 2006;118(8):1984-91.
2006: Rosenbloom A J; Ferris R L; Sipe D M; Riddler S A; Connolly N C; Abe K; Whiteside T L
In vitro and in vivo protein sampling by combined microdialysis and ultrafiltration.
Journal of immunological methods 2006;309(1-2):55-68.
2006: Whiteside Theresa L
Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention.
Seminars in cancer biology 2006;16(1):3-15.
2006: Wieckowski Eva; Whiteside Theresa L
Human tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profiles.
Immunologic research 2006;36(1-3):247-54.
2006: Whiteside Theresa L
The role of immune cells in the tumor microenvironment.
Cancer treatment and research 2006;130():103-24.
2005: Albers Andreas; Abe Koji; Hunt Jennifer; Wang Jun; Lopez-Albaitero Andres; Schaefer Carsten; Gooding William; Whiteside Theresa L; Ferrone Soldano; DeLeo Albert; Ferris Robert L
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Cancer research 2005;65(23):11146-55.
2005: Kim Jeong-Whun; Ferris Robert L; Whiteside Theresa L
Chemokine C receptor 7 expression and protection of circulating CD8+ T lymphocytes from apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7901-10.
2005: Albers Andreas E; Ferris Robert L; Kim Grace G; Chikamatsu Kazuaki; DeLeo Albert B; Whiteside Theresa L
Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
Cancer immunology, immunotherapy : CII 2005;54(11):1072-81.
2005: Tourkova Irina L; Shurin Galina V; Chatta Gurkamal S; Perez Lori; Finke James; Whiteside Theresa L; Ferrone Soldano; Shurin Michael R
Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):3045-52.
2005: Kuss Iris; Schaefer Carsten; Godfrey Tony E; Ferris Robert L; Harris Jeffrey M; Gooding William; Whiteside Theresa L
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.
Clinical immunology (Orlando, Fla.) 2005;116(1):27-36.
2005: Evans Christopher H; Robbins Paul D; Ghivizzani Steven C; Wasko Mary Chester; Tomaino Matthew M; Kang Richard; Muzzonigro Thomas A; Vogt Molly; Elder Elaine M; Whiteside Theresa L; Watkins Simon C; Herndon James H
Gene transfer to human joints: progress toward a gene therapy of arthritis.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(24):8698-703.
2005: Hathaway Bridget; Landsittel Douglas P; Gooding William; Whiteside Theresa L; Grandis Jennifer R; Siegfried Jill M; Bigbee William L; Ferris Robert L
Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients.
The Laryngoscope 2005;115(3):522-7.
2005: Lotze Michael T; Wang Ena; Marincola Francesco M; Hanna Nabil; Bugelski Peter J; Burns Christine A; Coukos George; Damle Nitin; Godfrey Tony E; Howell W Martin; Panelli Monica C; Perricone Michael A; Petricoin Emanuel F; Sauter Guido; Scheibenbogen Carmen; Shivers Steven C; Taylor D Lansing; Weinstein John N; Whiteside Theresa L
Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2005;28(2):79-119.
2005: Schaefer C; Kim G G; Albers A; Hoermann K; Myers E N; Whiteside T L
Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer.
British journal of cancer 2005;92(5):913-20.
2005: Kim Jeong Whun; Wieckowski Eva; Taylor Douglas D; Reichert Torsten E; Watkins Simon; Whiteside Theresa L
Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1010-20.
2005: Whiteside Theresa L
Immunobiology of head and neck cancer.
Cancer metastasis reviews 2005;24(1):95-105.
2005: Kuss I; Hathaway B; Ferris R L; Gooding W; Whiteside T L
Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Advances in oto-rhino-laryngology 2005;62():161-72.
2005: Hoffmann Thomas K; Bier Henning; Donnenberg Albert D; Whiteside Theresa L; De Leo Albert B
p53 as an immunotherapeutic target in head and neck cancer.
Advances in oto-rhino-laryngology 2005;62():151-60.
2004: Li Shen; Xu Jun; Makarenkova Valeria P; Tjandrawan Tjendimin; Vakkila Jukka; Reichert Torsten; Gooding William; Lagenaur Carl F; Achim Cristian L; Chambers William H; Herberman Ronald B; Whiteside Theresa L; Vujanovic Nikola L
A novel epitope of N-CAM defines precursors of human adherent NK cells.
Journal of leukocyte biology 2004;76(6):1187-99.
2004: Hoffmann Thomas K; Bier Henning; Whiteside Theresa L
Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
Cancer immunology, immunotherapy : CII 2004;53(12):1055-67.
2004: Sirianni Nicky; Ha Patrick K; Oelke Mattias; Califano Joseph; Gooding William; Westra William; Whiteside Theresa L; Koch Wayne M; Schneck Jonathan P; DeLeo Albert; Ferris Robert L
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6929-37.
2004: Whiteside Theresa L
Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer?
Cancer immunology, immunotherapy : CII 2004;53(10):865-78.
2004: Kim Jeong-Whun; Tsukishiro Takashi; Johnson Jonas T; Whiteside Theresa L
Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5101-10.
2004: Whiteside Theresa L; Stanson Joanna; Shurin Michael R; Ferrone Soldano
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(3):1526-34.
2004: Kuss Iris; Hathaway Bridget; Ferris Robert L; Gooding William; Whiteside Theresa L
Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3755-62.
2004: Wang Jun; Xi Liqiang; Hunt Jennifer L; Gooding William; Whiteside Theresa L; Chen Zhuo; Godfrey Tony E; Ferris Robert L
Expression pattern of chemokine receptor 6 (CCR6) and CCR7 in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype.
Cancer research 2004;64(5):1861-6.
2004: Whiteside Theresa L; Odoux Christine
Dendritic cell biology and cancer therapy.
Cancer immunology, immunotherapy : CII 2004;53(3):240-8.
2003: Tsukishiro Takashi; Donnenberg Albert D; Whiteside Theresa L
Rapid turnover of the CD8(+)CD28(-) T-cell subset of effector cells in the circulation of patients with head and neck cancer.
Cancer immunology, immunotherapy : CII 2003;52(10):599-607.
2003: Okada Hideho; Lieberman Frank S; Edington Howard D; Witham Timothy F; Wargo Mark J; Cai Quan; Elder Elaine H; Whiteside Theresa L; Schold S Clifford; Pollack Ian F
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy.
Journal of neuro-oncology 2003;64(1-2):13-20.
2003: Whiteside Theresa L; Gooding William
Immune monitoring of human gene therapy trials: potential application to leukemia and lymphoma.
Blood cells, molecules & diseases 2003;31(1):63-71.
2003: Chikamatsu Kazuaki; Albers Andreas; Stanson Joanna; Kwok William W; Appella Ettore; Whiteside Theresa L; DeLeo Albert B
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.
Cancer research 2003;63(13):3675-81.
2003: Bauernhofer T; Kuss I; Friebe-Hoffmann U; Baum A S; Dworacki G; Vonderhaar B K; Whiteside T L
Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.
British journal of cancer 2003;88(8):1301-9.
2003: Zhang Li-Fang; Gao Wei-Min; Gealy Robert; Weissfeld Joel; Elder Elaine; Whiteside Theresa L; Keohavong Phouthone
Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer.
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2003;8(2):156-61.
2003: Whiteside Theresa L
22. Immune responses to malignancies.
The Journal of allergy and clinical immunology 2003;111(2 Suppl):S677-86.
2003: Whiteside Theresa L; Zhao Yongxiang; Tsukishiro Takashi; Elder Elaine M; Gooding William; Baar Joseph
Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):641-9.
2003: Kuss I; Donnenberg A D; Gooding W; Whiteside T L
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.
British journal of cancer 2003;88(2):223-30.
2003: Bauernhofer Thomas; Kuss Iris; Henderson Brent; Baum Andrew S; Whiteside Theresa L
Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
European journal of immunology 2003;33(1):119-24.
2002: Kuss Iris; Rabinowich Hannah; Gooding William; Edwards Robert; Whiteside Theresa L
Expression of zeta in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma.
Cancer biotherapy & radiopharmaceuticals 2002;17(6):631-40.
2002: Whiteside Theresa L
Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy.
Vaccine 2002;20 Suppl 4():A46-51.
2002: Whiteside Theresa L
Cytokine assays.
BioTechniques 2002;Suppl():4-8, 10, 12-5.
2002: Kirkwood John M; Richards Thomas; Zarour Hassane M; Sosman Jeffrey; Ernstoff Marc; Whiteside Theresa L; Ibrahim Joseph; Blum Ronald; Wieand Samuel; Mascari Ruth
Immunomodulatory effects of high-dose and low-dose interferon alpha2b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690.
Cancer 2002;95(5):1101-12.
2002: Hoffmann Thomas K; Dworacki Grzegorz; Tsukihiro Takashi; Meidenbauer Norbert; Gooding William; Johnson Jonas T; Whiteside Theresa L
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(8):2553-62.
2002: Beckebaum Susanne; Cicinnati Vito R; Dworacki Grzegorz; Müller-Berghaus Jan; Stolz Donna; Harnaha Jo; Whiteside Theresa L; Thomson Angus W; Lu Lina; Fung John J; Bonham C Andrew
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection.
Clinical immunology (Orlando, Fla.) 2002;104(2):138-50.
2002: Whiteside Theresa L; Gambotto Andrea; Albers Andreas; Stanson Joanna; Cohen Edward P
Human tumor-derived genomic DNA transduced into a recipient cell induces tumor-specific immune responses ex vivo.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(14):9415-20.
2002: Hoffmann Thomas K; Donnenberg Albert D; Finkelstein Sydney D; Donnenberg Vera S; Friebe-Hoffmann Ulrike; Myers Eugene N; Appella Ettore; DeLeo Albert B; Whiteside Theresa L
Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Cancer research 2002;62(12):3521-9.
2002: Hoffmann Thomas K; Müller-Berghaus Jan; Ferris Robert L; Johnson Jonas T; Storkus Walter J; Whiteside Theresa L
Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1787-93.
2002: Basse Per H; Whiteside Theresa L; Herberman Ronald B
Cancer immunotherapy with interleukin-2-activated natural killer cells.
Molecular biotechnology 2002;21(2):161-70.
2002: Asai Tadao; Storkus Walter J; Mueller-Berghaus Jan; Knapp William; DeLeo Albert B; Chikamatsu Kazuaki; Whiteside Theresa L
In vitro generated cytolytic T lymphocytes reactive against head and neck cancer recognize multiple epitopes presented by HLA-A2, including peptides derived from the p53 and MDM-2 proteins.
Cancer immunity : a journal of the Academy of Cancer Immunology 2002;2():3.
2002: Bennouna Jaafar; Hildesheim Allan; Chikamatsu Kazuaki; Gooding William; Storkus Walter J; Whiteside Theresa L
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses.
Journal of immunological methods 2002;261(1-2):145-56.
2002: Whiteside Theresa L
Tumor-induced death of immune cells: its mechanisms and consequences.
Seminars in cancer biology 2002;12(1):43-50.
2002: Lu Ganwei; Janjic Bratislav M; Janjic Jelena; Whiteside Theresa L; Storkus Walter J; Vujanovic Nikola L
Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1831-9.
2002: Janjic Bratislav M; Lu Ganwei; Pimenov Alexei; Whiteside Theresa L; Storkus Walter J; Vujanovic Nikola L
Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(4):1823-30.
2002: Hoffmann Thomas K; Loftus Douglas J; Nakano Koji; Maeurer Markus J; Chikamatsu Kazuaki; Appella Ettore; Whiteside Theresa L; DeLeo Albert B
The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(3):1338-47.
2002: Meidenbauer N; Gooding W; Spitler L; Harris D; Whiteside T L
Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancer.
British journal of cancer 2002;86(2):168-78.
2001: Kao H; Marto J A; Hoffmann T K; Shabanowitz J; Finkelstein S D; Whiteside T L; Hunt D F; Finn O J
Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.
The Journal of experimental medicine 2001;194(9):1313-23.
2001: Whiteside T L
Isolation of human NK cells and generation of LAK activity.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 7():Unit 7.7.
2001: Whiteside T L
Measurement of cytotoxic activity of NK/LAK cells.
Current protocols in immunology / edited by John E. Coligan ... [et al.] 2001;Chapter 7():Unit 7.18.
2001: Dworacki G; Meidenbauer N; Kuss I; Hoffmann T K; Gooding W; Lotze M; Whiteside T L
Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(3 Suppl):947s-957s.
2001: Okada H; Pollack I F; Lieberman F; Lunsford L D; Kondziolka D; Schiff D; Attanucci J; Edington H; Chambers W; Kalinski P; Kinzler D; Whiteside T; Elder E; Potter D
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response.
Human gene therapy 2001;12(5):575-95.
2001: Hoffmann T K; Meidenbauer N; Müller-Berghaus J; Storkus W J; Whiteside T L
Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(2):162-71.
2001: Whiteside T L
Immunobiology and immunotherapy of head and neck cancer.
Current oncology reports 2001;3(1):46-55.
2000: Hoffmann T K; Donnenberg V S; Friebe-Hoffmann U; Meyer E M; Rinaldo C R; DeLeo A B; Whiteside T L; Donnenberg A D
Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
Cytometry 2000;41(4):321-8.
2000: Hoffmann T K; Nakano K; Elder E M; Dworacki G; Finkelstein S D; Appella E; Whiteside T L; DeLeo A B
Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5938-44.
2000: Hoffmann T K; Meidenbauer N; Dworacki G; Kanaya H; Whiteside T L
Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells.
Cancer research 2000;60(13):3542-9.
2000: Kirkwood J M; Mascari R A; Edington H D; Rabkin M S; Day R S; Whiteside T L; Vlock D R; Shipe-Spotloe J M
Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
Cancer 2000;88(12):2693-702.
2000: Whiteside T L
Immunologic monitoring of clinical trials in patients with cancer: technology versus common sense.
Immunological investigations 2000;29(2):149-62.
2000: Ranieri E; Kierstead L S; Zarour H; Kirkwood J M; Lotze M T; Whiteside T; Storkus W J
Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading.
Immunological investigations 2000;29(2):121-5.
2000: Lang S; Atarashi Y; Nishioka Y; Stanson J; Meidenbauer N; Whiteside T L
B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
Cellular immunology 2000;201(2):132-43.
2000: Whiteside T L
Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.
Clinical and diagnostic laboratory immunology 2000;7(3):327-32.
2000: Meidenbauer N; Harris D T; Spitler L E; Whiteside T L
Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer.
The Prostate 2000;43(2):88-100.
2000: Saito T; Dworacki G; Gooding W; Lotze M T; Whiteside T L
Spontaneous apoptosis of CD8+ T lymphocytes in peripheral blood of patients with advanced melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1351-64.
2000: Herberman R B; Whiteside T L
Summary of the International Cancer Microenvironment from meeting in Pittsburgh, Pennsylvania on October 3-6, 1999.
Cancer research 2000;60(5):1465-9.
2000: Okada H; Pollack I F; Lotze M T; Lunsford L D; Kondziolka D; Lieberman F; Schiff D; Attanucci J; Edington H; Chambers W; Robbins P; Baar J; Kinzler D; Whiteside T; Elder E
Gene therapy of malignant gliomas: a phase I study of IL-4-HSV-TK gene-modified autologous tumor to elicit an immune response.
Human gene therapy 2000;11(4):637-53.
2000: Gastman B R; Johnson D E; Whiteside T L; Rabinowich H
Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events.
Blood 2000;95(6):2015-23.
2000: Asai T; Storkus W J; Whiteside T L
Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines.
Clinical and diagnostic laboratory immunology 2000;7(2):145-54.
2000: Suminami Y; Nagashima S; Vujanovic N L; Hirabayashi K; Kato H; Whiteside T L
Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1.
British journal of cancer 2000;82(4):981-9.
2000: Lotze M T; Shurin M; Esche C; Tahara H; Storkus W; Kirkwood J M; Whiteside T L; Elder E M; Okada H; Robbins P
Interleukin-2: developing additional cytokine gene therapies using fibroblasts or dendritic cells to enhance tumor immunity.
The cancer journal from Scientific American 2000;6 Suppl 1():S61-6.
2000: Reichert T E; Nagashima S; Kashii Y; Stanson J; Gao G; Dou Q P; Whiteside T L
Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Oncogene 2000;19(4):514-25.
2000: deMagalhaes-Silverman M; Donnenberg A; Lembersky B; Elder E; Lister J; Rybka W; Whiteside T; Ball E
Posttransplant adoptive immunotherapy with activated natural killer cells in patients with metastatic breast cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2000;23(1):154-60.
1999: Shpilberg O; Wilson J; Whiteside T L; Herberman R B
Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group.
Leukemia & lymphoma 1999;36(1-2):109-21.
1999: Reichert T E; Kashii Y; Stanson J; Zeevi A; Whiteside T L
The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.
British journal of cancer 1999;81(5):822-31.
1999: Kashii Y; Giorda R; Herberman R B; Whiteside T L; Vujanovic N L
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5358-66.
1999: Gastman B R; Atarshi Y; Reichert T E; Saito T; Balkir L; Rabinowich H; Whiteside T L
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
Cancer research 1999;59(20):5356-64.
1999: Whiteside T L
Signaling defects in T lymphocytes of patients with malignancy.
Cancer immunology, immunotherapy : CII 1999;48(7):346-52.
1999: Chikamatsu K; Reichert T E; Kashii Y; Saito T; Kawashiri S; Yamamoto E; Whiteside T L
Immunotherapy with effector cells and IL-2 of lymph node metastases of human squamous-cell carcinoma of the head and neck established in nude mice.
International journal of cancer. Journal international du cancer 1999;82(4):532-7.
1999: Rosenbloom A J; Pinsky M R; Napolitano C; Nguyen T S; Levann D; Pencosky N; Dorrance A; Ray B K; Whiteside T
Suppression of cytokine-mediated beta2-integrin activation on circulating neutrophils in critically ill patients.
Journal of leukocyte biology 1999;66(1):83-9.
1999: Chikamatsu K; Nakano K; Storkus W J; Appella E; Lotze M T; Whiteside T L; DeLeo A B
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1281-8.
1999: Saito T; Kuss I; Dworacki G; Gooding W; Johnson J T; Whiteside T L
Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(6):1263-73.
1999: Gastman B R; Johnson D E; Whiteside T L; Rabinowich H
Caspase-mediated degradation of T-cell receptor zeta-chain.
Cancer research 1999;59(7):1422-7.
1999: Nalesnik M A; Zeevi A; Randhawa P S; Faro A; Spichty K J; Demetris A J; Fung J J; Whiteside T L; Starzl T E
Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.
Clinical transplantation 1999;13(1 Pt 1):39-44.
1999: Kuss I; Saito T; Johnson J T; Whiteside T L
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):329-34.
1998: Logan T F; Banner B; Rao U; Ernstoff M S; Wolmark N; Whiteside T L; Miketic L; Kirkwood J M
Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy.
Clinical and experimental immunology 1998;114(3):347-54.
1998: Whiteside T L; Friberg D
Natural killer cells and natural killer cell activity in chronic fatigue syndrome.
The American journal of medicine 1998;105(3A):27S-34S.
1998: Walgenbach K J; Heeckt P F; Kalff J C; Stanson J; Whiteside T L; Hirner A; Bauer A J
Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation.
Transplantation proceedings 1998;30(6):2600.
1998: Zhang H; Yousem S A; Franklin W A; Elder E; Landreneau R; Ferson P; Keenan R; Whiteside T; Levitt M L
Differentiation and programmed cell death-related intermediate biomarkers for the development of non-small cell lung cancer: a pilot study.
Human pathology 1998;29(9):965-71.
1998: Reichert T E; Rabinowich H; Johnson J T; Whiteside T L
Mechanisms responsible for signaling and functional defects.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1998;21(4):295-306.
1998: Whiteside T L; Rabinowich H
The role of Fas/FasL in immunosuppression induced by human tumors.
Cancer immunology, immunotherapy : CII 1998;46(4):175-84.
1998: Rabinowich H; Reichert T E; Kashii Y; Gastman B R; Bell M C; Whiteside T L
Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.
The Journal of clinical investigation 1998;101(11):2579-88.
1998: Whiteside T L; Sung M W; Nagashima S; Chikamatsu K; Okada K; Vujanovic N L
Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1135-45.
1998: Nagashima S; Mailliard R; Kashii Y; Reichert T E; Herberman R B; Robbins P; Whiteside T L
Stable transduction of the interleukin-2 gene into human natural killer cell lines and their phenotypic and functional characterization in vitro and in vivo.
Blood 1998;91(10):3850-61.
1998: Reichert T E; Watkins S; Stanson J; Johnson J T; Whiteside T L
Endogenous IL-2 in cancer cells: a marker of cellular proliferation.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1998;46(5):603-11.
1998: Suminami Y; Kashii Y; Law J C; Lin W C; Stanson J; Reichert T E; Rabinowich H; Whiteside T L
Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells.
Oncogene 1998;16(10):1309-17.
1998: Randhawa P S; Whiteside T L; Zeevi A; Elder E M; Rao A S; Demetris A J; Weng X; Valdivia L A; Rakela J; Nalesnik M A
Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease.
Transplantation 1998;65(2):264-8.
1998: Whiteside T L
Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects.
Advances in experimental medicine and biology 1998;451():167-71.
1998: Whiteside T L; Vujanovic N L; Herberman R B
Natural killer cells and tumor therapy.
Current topics in microbiology and immunology 1998;230():221-44.
1997: Lotze M T; Hellerstedt B; Stolinski L; Tueting T; Wilson C; Kinzler D; Vu H; Rubin J T; Storkus W; Tahara H; Elder E; Whiteside T
The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.
The cancer journal from Scientific American 1997;3 Suppl 1():S109-14.
1997: Randhawa P; Whiteside T; Zeevi A; Nalesnik M; Alvares C; Gollin S M; Demetris J; Locker J
In vitro culture of B-lymphocytes derived from Epstein-Barr-virus-associated posttransplant lymphoproliferative disease: cytokine production and effect of interferon-alpha.
In vitro cellular & developmental biology. Animal 1997;33(10):803-8.
1997: Nagashima S; Reichert T E; Kashii Y; Suminami Y; Chikamatsu K; Whiteside T L
In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Cancer gene therapy 1997;4(6):366-76.
1997: Muldoon M F; Flory J D; Marsland A; Manuck S B; Whiteside T L; Rabin B
Effects of lovastatin on the immune system.
The American journal of cardiology 1997;80(10):1391-4.
1997: Logan T F; Gooding W E; Whiteside T L; Ernstoff M S; Kaplan S S; Miketic L; Vlock D R; Tompkins C; Wood D L; Nadler P I; Kirkwood J M
Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(5):387-98.
1997: Muldoon M F; Marsland A; Flory J D; Rabin B S; Whiteside T L; Manuck S B
Immune system differences in men with hypo- or hypercholesterolemia.
Clinical immunology and immunopathology 1997;84(2):145-9.
1997: Nagashima S; Kashii Y; Reichert T E; Suminami Y; Suzuki T; Whiteside T L
Human gastric carcinoma transduced with the IL-2 gene: increased sensitivity to immune effector cells in vitro and in vivo.
International journal of cancer. Journal international du cancer 1997;72(1):174-83.
1997: Zhu D; Keohavong P; Finkelstein S D; Swalsky P; Bakker A; Weissfeld J; Srivastava S; Whiteside T L
K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.
Cancer research 1997;57(12):2485-92.
1997: Kirkwood J M; Wilson J; Whiteside T L; Donnelly S; Herberman R B
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.
Cancer immunology, immunotherapy : CII 1997;44(3):137-49.
1997: Lai P; Rabinowich H; Crowley-Nowick P A; Bell M C; Mantovani G; Whiteside T L
Alterations in expression and function of signal transducing proteins in tumor-associated T and natural killer cells in ovarian carcinoma.
Biochemical Society transactions 1997;25(2):218S.
1997: Keohavong P; Zhu D; Whiteside T L; Swalsky P; Bakker A; Elder E M; Siegfried J M; Srivastava S; Finkelstein S D
Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
Analytical biochemistry 1997;247(2):394-403.
1997: Nalesnik M A; Rao A S; Furukawa H; Pham S; Zeevi A; Fung J J; Klein G; Gritsch H A; Elder E; Whiteside T L; Starzl T E
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.
Transplantation 1997;63(9):1200-5.
1997: Okada K; Yasumura S; Muller-Fleckenstein I; Fleckenstein B; Talib S; Koldovsky U; Whiteside T L
Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
Cellular immunology 1997;177(1):35-48.
1997: Kirkwood J M; Bryant J; Schiller J H; Oken M M; Borden E C; Whiteside T L
Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group.
Journal of immunotherapy (Hagerstown, Md. : 1997) 1997;20(2):146-57.
1997: von Zons P; Crowley-Nowick P; Friberg D; Bell M; Koldovsky U; Whiteside T L
Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.
Clinical and diagnostic laboratory immunology 1997;4(2):202-7.
1997: Francavilla A; Vujanovic N L; Polimeno L; Azzarone A; Iacobellis A; Deleo A; Hagiya M; Whiteside T L; Starzl T E
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions.
Hepatology (Baltimore, Md.) 1997;25(2):411-5.
1996: Vlock D R; Andersen J; Kalish L A; Johnson J T; Kirkwood J M; Whiteside T; Herberman R B; Adams G S; Oken M M; Haselow R E
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlates.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):433-42.
1996: Rabinowich H; Suminami Y; Reichert T E; Crowley-Nowick P; Bell M; Edwards R; Whiteside T L
Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian carcinoma.
International journal of cancer. Journal international du cancer 1996;68(3):276-84.
1996: Rabinowich H; Manciulea M; Herberman R B; Whiteside T L
Beta1 integrin-mediated activation of focal adhesion kinase and its association with Fyn and Zap-70 in human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(9):3860-8.
1996: Lotze M T; Zitvogel L; Campbell R; Robbins P D; Elder E; Haluszczak C; Martin D; Whiteside T L; Storkus W J; Tahara H
Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.
Annals of the New York Academy of Sciences 1996;795():440-54.
1996: Walgenbach K J; Heeckt P F; Stanson J D; Whiteside T L; Bauer A J
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts.
Transplantation proceedings 1996;28(5):2454.
1996: Walgenbach K J; Heeckt P F; Stanson J D; Whiteside T L; Bauer A J
Increased expression of transforming growth factor-beta during chronic rejection.
Transplantation proceedings 1996;28(5):2450.
1996: Rabinowich H; Banks M; Reichert T E; Logan T F; Kirkwood J M; Whiteside T L
Expression and activity of signaling molecules in T lymphocytes obtained from patients with metastatic melanoma before and after interleukin 2 therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1263-74.
1996: Rabinowich H; Manciulea M; Metes D; Sulica A; Herberman R B; Corey S J; Whiteside T L
Physical and functional association of Fc mu receptor on human natural killer cells with the zeta- and Fc epsilon RI gamma-chains and with src family protein tyrosine kinases.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(4):1485-91.
1996: Vujanovic N L; Nagashima S; Herberman R B; Whiteside T L
Nonsecretory apoptotic killing by human NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(3):1117-26.
1996: Whiteside T L; Chikamatsu K; Nagashima S; Okada K
Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer.
Anticancer research 1996;16(4C):2357-64.
1996: Su G L; Walgenbach K J; Heeckt P H; Wang Q; Halfter W; Whiteside T L; Bauer A J
Increased expression of interferon-gamma in a rat model of chronic intestinal allograft rejection.
Transplantation 1996;62(2):242-8.
1996: Sung M W; Nagashima S; Johnson J T; Van Dongen G A; Whiteside T L
The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets.
Cellular immunology 1996;171(1):20-9.
1996: Evans C H; Robbins P D; Ghivizzani S C; Herndon J H; Kang R; Bahnson A B; Barranger J A; Elders E M; Gay S; Tomaino M M; Wasko M C; Watkins S C; Whiteside T L; Glorioso J C; Lotze M T; Wright T M
Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis.
Human gene therapy 1996;7(10):1261-80.
1996: Goydos J S; Elder E; Whiteside T L; Finn O J; Lotze M T
A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma.
The Journal of surgical research 1996;63(1):298-304.
1996: Sulica A; Metes D; Gherman M; Whiteside T L; Herberman R B
Divergent effects of Fc gamma RIIIA ligands on the functional activities of human natural killer cells in vitro.
European journal of immunology 1996;26(6):1199-203.
1996: Skoner D P; Whiteside T L; Wilson J W; Doyle W J; Herberman R B; Fireman P
Effect of influenza A virus infection on natural and adaptive cellular immunity.
Clinical immunology and immunopathology 1996;79(3):294-302.
1996: Silla L M; Pincus S M; Locker J D; Glover J; Elder E M; Donnenberg A D; Nardi N B; Bryant J; Ball E D; Whiteside T L
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
British journal of haematology 1996;93(2):375-85.
1996: Sung M W; Johnson J T; Van Dongen G; Whiteside T L
Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
International journal of cancer. Journal international du cancer 1996;66(3):393-9.
1996: Elder E M; Lotze M T; Whiteside T L
Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer.
Human gene therapy 1996;7(4):479-87.
1996: Lai P; Rabinowich H; Crowley-Nowick P A; Bell M C; Mantovani G; Whiteside T L
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):161-73.
1996: Myers J N; Yasumura S; Suminami Y; Hirabayashi H; Lin W c; Johnson J T; Lotze M T; Whiteside T L
Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):127-35.
1996: Manciulea M; Rabinowich H; Sulica A; Lin W C; Whiteside T L; DeLeo A; Herberman R B; Corey S J
Divergent phosphotyrosine signaling via Fc gamma RIIIA on human NK cells.
Cellular immunology 1996;167(1):63-71.
1995: Lin W C; Yasumura S; Suminami Y; Sung M W; Nagashima S; Stanson J; Whiteside T L
Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(10):4805-16.
1995: Silla L M; Whiteside T L; Ball E D
The role of natural killer cells in the treatment of chronic myeloid leukemia.
Journal of hematotherapy 1995;4(4):269-79.
1995: Law J C; Whiteside T L; Gollin S M; Weissfeld J; El-Ashmawy L; Srivastava S; Landreneau R J; Johnson J T; Ferrell R E
Variation of p53 mutational spectra between carcinoma of the upper and lower respiratory tract.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(7):763-8.
1995: Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside T L; Herberman R B
Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Cellular immunology 1995;163(2):167-77.
1995: Rosenbloom A J; Pinsky M R; Bryant J L; Shin A; Tran T; Whiteside T
Leukocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. Correlation with serum interleukin-6 levels and organ dysfunction.
JAMA : the journal of the American Medical Association 1995;274(1):58-65.
1995: Lister J; Rybka W B; Donnenberg A D; deMagalhaes-Silverman M; Pincus S M; Bloom E J; Elder E M; Ball E D; Whiteside T L
Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(6):607-14.
1995: Sung M W; Yasumura S; Johnson J T; Van Dongen G A; Whiteside T L
Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1995;61(6):864-72.
1995: Vujanovic N L; Polimeno L; Azzarone A; Francavilla A; Chambers W H; Starzl T E; Herberman R B; Whiteside T L
Changes of liver-resident NK cells during liver regeneration in rats.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(12):6324-38.
1995: Melhem M F; Law J C; el-Ashmawy L; Johnson J T; Landreneau R J; Srivastava S; Whiteside T L
Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers.
The American journal of pathology 1995;146(5):1170-7.
1995: Silla L M; Chen J; Zhong R K; Whiteside T L; Ball E D
Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
British journal of haematology 1995;89(4):712-8.
1995: Rabinowich H; Lin W C; Manciulea M; Herberman R B; Whiteside T L
Induction of protein tyrosine phosphorylation in human natural killer cells by triggering via alpha 4 beta 1 or alpha 5 beta 1 integrins.
Blood 1995;85(7):1858-64.
1995: Hirabayashi H; Yasumura S; Lin W C; Amoscato A; Johnson J T; Herberman R B; Whiteside T L
Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
Archives of otolaryngology--head & neck surgery 1995;121(3):285-92.
1995: Rabinowich H; Lin W C; Amoscato A; Herberman R B; Whiteside T L
Expression of vitronectin receptor on human NK cells and its role in protein phosphorylation, cytokine production, and cell proliferation.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(3):1124-35.
1995: Vujanovic N L; Yasumura S; Hirabayashi H; Lin W C; Watkins S; Herberman R B; Whiteside T L
Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(1):281-9.
1995: Sulica A; Chambers W H; Manciulea M; Metes D; Corey S; Rabinowich H; Whiteside T L; Herberman R B
Divergent signal transduction pathways and effects on natural killer cell functions induced by interaction of Fc receptors with physiologic ligands or antireceptor antibodies.
Natural immunity 1995;14(3):123-33.
1994: Yasumura S; Amoscato A; Hirabayashi H; Lin W C; Whiteside T L
Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck.
Cancer immunology, immunotherapy : CII 1994;39(6):407-15.
1994: Appasamy R; Bryant J; Hassanein T; Van Thiel D H; Whiteside T L
Effects of therapy with interferon-alpha on peripheral blood lymphocyte subsets and NK activity in patients with chronic hepatitis C.
Clinical immunology and immunopathology 1994;73(3):350-7.
1994: Metes D; Galatiuc C; Moldovan I; Morel P A; Chambers W H; DeLeo A B; Rabinowich H; Schall R; Whiteside T L; Sulica A
Expression and function of Fc gamma RII on human natural killer cells.
Natural immunity 1994;13(6):289-300.
1994: Rabinowich H; Lin W C; Herberman R B; Whiteside T L
Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(8):3504-13.
1994: Yasumura S; Lin W C; Weidmann E; Hebda P; Whiteside T L
Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2.
International journal of cancer. Journal international du cancer 1994;59(2):225-34.
1994: Snyderman C H; Klapan I; Milanovich M; Heo D S; Wagner R; Schwartz D; Johnson J T; Whiteside T L
Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1994;111(3 Pt 1):189-96.
1994: Whiteside T L; Parmiani G
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.
Cancer immunology, immunotherapy : CII 1994;39(1):15-21.
1994: Yasumura S; Lin W C; Hirabayashi H; Vujanovic N L; Herberman R B; Whiteside T L
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
Cancer research 1994;54(14):3808-16.
1994: Whiteside T L
Concluding comments: immunologic intervention in therapy of cancer.
Clinical immunology and immunopathology 1994;71(3):263-4.
1994: Whiteside T L
Symposium-in-writing. Introduction.
Clinical immunology and immunopathology 1994;71(3):247.
1994: Yasumura S; Weidmann E; Hirabayashi H; Johnson J T; Herberman R B; Whiteside T L
HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
International journal of cancer. Journal international du cancer 1994;57(3):297-305.
1994: Friberg D; Bryant J; Shannon W; Whiteside T L
In vitro cytokine production by normal human peripheral blood mononuclear cells as a measure of immunocompetence or the state of activation.
Clinical and diagnostic laboratory immunology 1994;1(3):261-8.
1994: Whiteside T L
Cytokines and cytokine measurements in a clinical laboratory.
Clinical and diagnostic laboratory immunology 1994;1(3):257-60.
1994: Goldfarb R H; Whiteside T L; Basse P H; Lin W C; Vujanovic N; Herberman R B
Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
Natural immunity 1994;13(2-3):131-40.
1994: Whiteside T L; Herberman R B
Role of human natural killer cells in health and disease.
Clinical and diagnostic laboratory immunology 1994;1(2):125-33.
1994: McMahon D K; Armstrong J A; Huang X L; Rinaldo C R; Gupta P; Whiteside T L; Pazin G J; Tripoli C; Ho M
A phase I study of subcutaneous recombinant interleukin-2 in patients with advanced HIV disease while on zidovudine.
AIDS (London, England) 1994;8(1):59-66.
1994: Rabinowich H; Pricop L; Herberman R B; Whiteside T L
Expression and function of CD7 molecule on human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(2):517-26.
1994: Vujanovic N L; Whiteside T L
Phenotypic and functional characteristics of human A-NK cells.
Immunology series 1994;61():41-54.
1994: Whiteside T L; Goldfarb R H
Immunomodulation and antitumor mechanisms. Introduction.
Immunology series 1994;61():179-81.
1994: Whiteside T L; Goldfarb R H
Antitumor effector cells: extravasation and control of metastasis.
Immunology series 1994;61():159-73.
1994: Whiteside T L
Tumor-infiltrating lymphocytes in human solid tumors.
Immunology series 1994;61():137-48.
1994: Whiteside T L
Tumor microenvironment and immune effector cells. Introduction.
Immunology series 1994;61():133-6.
1993: Whiteside T L; Letessier E; Hirabayashi H; Vitolo D; Bryant J; Barnes L; Snyderman C; Johnson J T; Myers E; Herberman R B
Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.
Cancer research 1993;53(23):5654-62.
1993: Rabinowich H; Herberman R B; Whiteside T L
Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells.
Cellular immunology 1993;152(2):481-98.
1993: Lin W C; Yasumura S; Whiteside T L
Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
Archives of otolaryngology--head & neck surgery 1993;119(11):1229-35.
1993: Vujanovic N L; Rabinowich H; Lee Y J; Jost L; Herberman R B; Whiteside T L
Distinct phenotypic and functional characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic.
Cellular immunology 1993;151(1):133-57.
1993: Weidmann E; Logan T F; Yasumura S; Kirkwood J M; Trucco M; Whiteside T L
Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Cancer research 1993;53(20):4745-9.
1993: Torpey D; Huang X L; Armstrong J; Ho M; Whiteside T; McMahon D; Pazin G; Heberman R; Gupta P; Tripoli C
Effects of adoptive immunotherapy with autologous CD8+ T lymphocytes on immunologic parameters: lymphocyte subsets and cytotoxic activity.
Clinical immunology and immunopathology 1993;68(3):263-72.
1993: Pricop L; Rabinowich H; Morel P A; Sulica A; Whiteside T L; Herberman R B
Characterization of the Fc mu receptor on human natural killer cells. Interaction with its physiologic ligand, human normal IgM, specificity of binding, and functional effects.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(6):3018-29.
1993: Vitolo D; Vujanovic N L; Rabinowich H; Schlesinger M; Herberman R B; Whiteside T L
Rapid Il-2-induced adherence of human natural killer cells. Expression of mRNA for cytokines and IL-2 receptors in adherent NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):1926-37.
1993: Rabinowich H; Sedlmayr P; Herberman R B; Whiteside T L
Response of human NK cells to IL-6 alterations of the cell surface phenotype, adhesion to fibronectin and laminin, and tumor necrosis factor-alpha/beta secretion.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(11):4844-55.
1993: Weidmann E; Elder E M; Trucco M; Lotze M T; Whiteside T L
Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
International journal of cancer. Journal international du cancer 1993;54(3):383-90.
1993: Yin X Y; Smith M L; Whiteside T L; Johnson J T; Herberman R B; Locker J
Abnormalities in the p53 gene in tumors and cell lines of human squamous-cell carcinomas of the head and neck.
International journal of cancer. Journal international du cancer 1993;54(2):322-7.
1993: Ho M; Armstrong J; McMahon D; Pazin G; Huang X L; Rinaldo C; Whiteside T; Tripoli C; Levine G; Moody D
A phase 1 study of adoptive transfer of autologous CD8+ T lymphocytes in patients with acquired immunodeficiency syndrome (AIDS)-related complex or AIDS.
Blood 1993;81(8):2093-101.
1993: Whiteside T L; Elder E M; Moody D; Armstrong J; Ho M; Rinaldo C; Huang X; Torpey D; Gupta P; McMahon D
Generation and characterization of ex vivo propagated autologous CD8+ cells used for adoptive immunotherapy of patients infected with human immunodeficiency virus.
Blood 1993;81(8):2085-92.
1993: Sulica A; Galatiuc C; Manciulea M; Bancu A C; DeLeo A; Whiteside T L; Herberman R B
Regulation of human natural cytotoxicity by IgG. IV. Association between binding of monomeric IgG to the Fc receptors on large granular lymphocytes and inhibition of natural killer (NK) cell activity.
Cellular immunology 1993;147(2):397-410.
1993: Yasumura S; Hirabayashi H; Schwartz D R; Toso J F; Johnson J T; Herberman R B; Whiteside T L
Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
Cancer research 1993;53(6):1461-8.
1993: Vaccarello L; Kanbour A; Kanbour-Shakir A; Whiteside T L
Tumor-infiltrating lymphocytes from ovarian tumors of low malignant potential.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1993;12(1):41-50.
1993: Vitolo D; Kanbour A; Johnson J T; Herberman R B; Whiteside T L
In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):371-7.
1992: Kantor T V; Friberg D; Medsger T A; Buckingham R B; Whiteside T L
Cytokine production and serum levels in systemic sclerosis.
Clinical immunology and immunopathology 1992;65(3):278-85.
1992: Weidmann E; Sacchi M; Plaisance S; Heo D S; Yasumura S; Lin W C; Johnson J T; Herberman R B; Azzarone B; Whiteside T L
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Cancer research 1992;52(21):5963-70.
1992: Weidmann E; Whiteside T L; Giorda R; Herberman R B; Trucco M
The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
Cancer research 1992;52(21):5913-20.
1992: Lotze M T; Zeh H J; Elder E M; Cai Q; Pippin B A; Rosenstein M M; Whiteside T L; Herberman R
Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1992;12(3):212-7.
1992: Shimizu Y; Demetris A J; Gollin S M; Storto P D; Bedford H M; Altarac S; Iwatsuki S; Herberman R B; Whiteside T L
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells.
International journal of cancer. Journal international du cancer 1992;52(2):252-60.
1992: Rabinowich H; Vitolo D; Altarac S; Herberman R B; Whiteside T L
Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(1):340-9.
1992: Vitolo D; Zerbe T; Kanbour A; Dahl C; Herberman R B; Whiteside T L
Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):573-80.
1992: Kantor T V; Whiteside T L; Friberg D; Buckingham R B; Medsger T A
Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.
Arthritis and rheumatism 1992;35(6):694-9.
1992: Hata K; Van Thiel D H; Herberman R B; Whiteside T L
Phenotypic and functional characteristics of lymphocytes isolated from liver biopsy specimens from patients with active liver disease.
Hepatology (Baltimore, Md.) 1992;15(5):816-23.
1992: Jost L M; Kirkwood J M; Whiteside T L
Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells.
Journal of immunological methods 1992;147(2):153-65.
1992: Sedlmayr P; Rabinowich H; Winkelstein A; Herberman R B; Whiteside T L
Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.
British journal of cancer 1992;65(2):222-8.
1992: Ernstoff M S; Gooding W; Nair S; Bahnson R R; Miketic L M; Banner B; Day R; Whiteside T; Titus-Ernstoff L; Kirkwood J M
Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.
Cancer research 1992;52(4):851-6.
1992: Bryant J; Day R; Whiteside T L; Herberman R B
Calculation of lytic units for the expression of cell-mediated cytotoxicity.
Journal of immunological methods 1992;146(1):91-103.
1992: Whiteside T L; Jost L M; Herberman R B
Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.
Critical reviews in oncology/hematology 1992;12(1):25-47.
1992: Whiteside T L; Herberman R B
Extravasation of antitumor effector cells.
Invasion & metastasis 1992;12(2):128-46.
1992: Whiteside T L
Tumor-infiltrating lymphocytes as antitumor effector cells.
Biotherapy (Dordrecht, Netherlands) 1992;5(1):47-61.
1992: Vitolo D; Letessier E M; Johnson J T; Whiteside T L
Immunologic effector cells in head and neck cancer.
Journal of the National Cancer Institute. Monographs 1992;(13):203-8.
1991: Whiteside T L; Wilson J; Bryant J; Zeevi A; Abu el-Magd K; Jain A; Alessiani M; Fung J; Herberman R B; Starzl T E
Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
Transplantation proceedings 1991;23(6):3047-51.
1991: Whiteside T L
Cancer therapy with tumor-infiltrating lymphocytes: evaluation of potential and limitations.
In vivo (Athens, Greece) 1991;5(6):553-9.
1991: Yin X Y; Donovan-Peluso M; Whiteside T L; Johnson J T; Day R; Herberman R B; Locker J
Gene amplification and gene dosage in cell lines derived from squamous cell carcinoma of the head and neck.
Genes, chromosomes & cancer 1991;3(6):443-54.
1991: Shimizu Y; Weidmann E; Iwatsuki S; Herberman R B; Whiteside T L
Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
Cancer research 1991;51(22):6153-62.
1991: Sedlmayr P; Rabinowich H; Elder E M; Ernstoff M S; Kirkwood J M; Herberman R B; Whiteside T L
Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.
Journal of immunotherapy : official journal of the Society for Biological Therapy 1991;10(5):336-46.
1991: Hata K; Van Thiel D H; Herberman R B; Whiteside T L
Natural killer activity of human liver-derived lymphocytes in various liver diseases.
Hepatology (Baltimore, Md.) 1991;14(3):495-503.
1991: Snyderman C H; Heo D S; Johnson J T; D'Amico F; Barnes L; Whiteside T L
Functional and phenotypic analysis of lymphocytes in head and neck cancer.
Archives of otolaryngology--head & neck surgery 1991;117(8):899-905.
1991: Letessier E M; Heo D S; Okarma T; Johnson J T; Herberman R B; Whiteside T L
Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Cancer research 1991;51(15):3891-9.
1991: Rabinowich H; Sedlmayr P; Herberman R B; Whiteside T L
Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.
Cellular immunology 1991;135(2):454-70.
1991: Pricop L; Galatiuc C; Manciulea M; DeLeo A; Sulica A; Herberman R B; Whiteside T L
Expression of Fc mu receptors on human natural killer cells.
Clinical immunology and immunopathology 1991;59(3):355-67.
1991: Sacchi M; Vitolo D; Sedlmayr P; Rabinowich H; Johnson J T; Herberman R B; Whiteside T L
Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2.
International journal of cancer. Journal international du cancer 1991;47(5):784-91.
1991: Sacchi M; Klapan I; Johnson J T; Whiteside T L
Antiproliferative effects of cytokines on squamous cell carcinoma.
Archives of otolaryngology--head & neck surgery 1991;117(3):321-6.
1991: Vlock D R; Johnson J; Myers E; Day R; Gooding W E; Whiteside T; Pelch K; Sigler B; Wagner R; Colao D
Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck.
Head & neck 1991;13(1):15-21.
1991: Melder R J; Walker E; Herberman R B; Whiteside T L
Adhesion characteristics of human interleukin 2-activated natural killer cells.
Cellular immunology 1991;132(1):177-92.
1991: Shimizu Y; Iwatsuki S; Herberman R B; Whiteside T L
Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors.
Cancer immunology, immunotherapy : CII 1991;32(5):280-8.
1991: Levy S M; Herberman R B; Lee J; Whiteside T; Beadle M; Heiden L; Simons A
Persistently low natural killer cell activity, age, and environmental stress as predictors of infectious morbidity.
Natural immunity and cell growth regulation 1991;10(6):289-307.
1990: Yoo Y K; Gavaler J B; Chen K; Whiteside T L; van Thiel D H
The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals.
Clinical and experimental immunology 1990;82(2):338-43.
1990: Storto P D; Saidman S L; Demetris A J; Letessier E; Whiteside T L; Gollin S M
Chromosomal breakpoints in cholangiocarcinoma cell lines.
Genes, chromosomes & cancer 1990;2(4):300-10.
1990: Letessier E M; Sacchi M; Johnson J T; Herberman R B; Whiteside T L
The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
Cellular immunology 1990;130(2):446-58.
1990: Ernstoff M S; Nair S; Bahnson R R; Miketic L M; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood J M
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1637-49.
1990: Hata K; Zhang X R; Iwatsuki S; Van Thiel D H; Herberman R B; Whiteside T L
Isolation, phenotyping, and functional analysis of lymphocytes from human liver.
Clinical immunology and immunopathology 1990;56(3):401-19.
1990: Melder R J; Balachandran R; Rinaldo C R; Gupta P; Whiteside T L; Herberman R B
Cytotoxic activity against HIV-infected monocytes by recombinant interleukin 2-activated natural killer cells.
AIDS research and human retroviruses 1990;6(8):1011-5.
1990: Melder R J; Walker E R; Herberman R B; Whiteside T L
Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
Journal of leukocyte biology 1990;48(2):163-73.
1990: Heo D S; Park J G; Hata K; Day R; Herberman R B; Whiteside T L
Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity.
Cancer research 1990;50(12):3681-90.
1990: Vaccarello L; Wang Y L; Whiteside T L
Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2.
Human immunology 1990;28(2):216-27.
1990: Sacchi M; Snyderman C H; Heo D S; Johnson J T; d'Amico F; Herberman R B; Whiteside T L
Local adoptive immunotherapy of human head and neck cancer xenografts in nude mice with lymphokine-activated killer cells and interleukin 2.
Cancer research 1990;50(10):3113-8.
1990: Ferrarini M; Steen V; Medsger T A; Whiteside T L
Functional and phenotypic analysis of T lymphocytes cloned from the skin of patients with systemic sclerosis.
Clinical and experimental immunology 1990;79(3):346-52.
1990: Yoo Y K; Heo D S; Hata K; Van Thiel D H; Whiteside T L
Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.
Gastroenterology 1990;98(2):259-68.
1990: Levy S M; Herberman R B; Whiteside T; Sanzo K; Lee J; Kirkwood J
Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients.
Psychosomatic medicine 1990;52(1):73-85.
1990: Chang Z L; Whiteside T L; Herberman R B
Immunoregulatory role of in vitro differentiated macrophages on human natural killer (NK)-cell activity.
Cellular immunology 1990;125(1):183-96.
1990: Whiteside T L; Bryant J; Day R; Herberman R B
Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.
Journal of clinical laboratory analysis 1990;4(2):102-14.
1990: Shadduck R K; Kaplan S S; Whiteside T L; Wing E J
Biological effects of recombinant human GM-CSF.
Progress in clinical and biological research 1990;352():365-74.
1990: Whiteside T L; Herberman R B
Serum and tissue banks for biological markers.
Immunology series 1990;53():55-68.
1990: Whiteside T L; Herberman R B
The biology of human natural killer cells.
Annali dell'Istituto superiore di sanità 1990;26(3-4):335-48.
1990: Levy S M; Herberman R B; Lee J; Whiteside T; Kirkwood J; McFeeley S
Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients. Confirmation of a model.
Natural immunity and cell growth regulation 1990;9(5):313-24.
1989: Wang Y L; Kaplan S; Whiteside T; Herberman R B
In vitro effects of an acyltripeptide, FK565, on antitumor effector activities and on metabolic activities of human monocytes and granulocytes.
Immunopharmacology 1989;18(3):213-22.
1989: Van Thiel D H; Chen K N; Chien M C; Dindzans V J; Gavaler J S; Whiteside T L
T-lymphocyte subsets in gut and blood of liver transplant recipients with and without cytomegalovirus gastroenteritis.
Digestive diseases and sciences 1989;34(11):1751-7.
1989: Yoo Y K; Gavaler J S; Chen K N; Dindzans V; Brouillette D E; Whiteside T L; Van Thiel D H
Alpha-interferon. Its effect upon lymphocyte subpopulations and HLA-DR expression within the liver.
Digestive diseases and sciences 1989;34(11):1758-64.
1989: Wang Y L; Si L S; Kanbour A; Herberman R B; Whiteside T L
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes.
Cancer research 1989;49(21):5979-85.
1989: Adler A; Albo V; Blatt J; Whiteside T L; Herberman R B
Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission.
Blood 1989;74(5):1690-7.
1989: Chen K; Gavaler J S; Van Thiel D H; Whiteside T
Phenotypic characterization of mononuclear infiltrate present in liver of biliary atresia.
Digestive diseases and sciences 1989;34(10):1564-70.
1989: Whiteside T L; Herberman R B
The role of natural killer cells in human disease.
Clinical immunology and immunopathology 1989;53(1):1-23.
1989: Heo D S; Snyderman C; Gollin S M; Pan S; Walker E; Deka R; Barnes E L; Johnson J T; Herberman R B; Whiteside T L
Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.
Cancer research 1989;49(18):5167-75.
1989: Schwarz R E; Iwatsuki S; Herberman R B; Whiteside T L
Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors.
Hepatology (Baltimore, Md.) 1989;10(2):221-7.
1989: Snyderman C H; Heo D S; Chen K; Whiteside T L; Johnson J T
T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer.
Head & neck 1989;11(4):331-6.
1989: Ferrarini M; Helfrich D J; Walker E R; Medsger T A; Whiteside T L
Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts.
The Journal of rheumatology 1989;16(6):837-41.
1989: Wang Y L; Whiteside T L; Friberg D; Herberman R B
In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
Immunopharmacology 1989;17(3):175-85.
1989: Chang Z L; Huang X L; Rinaldo C; Herberman R B; Whiteside T L
Up-regulation of natural killer activity of human immunodeficiency virus-infected patients by in vitro-differentiated macrophages.
Clinical immunology and immunopathology 1989;51(1):133-9.
1989: Wing E J; Magee D M; Whiteside T L; Kaplan S S; Shadduck R K
Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.
Blood 1989;73(3):643-6.
1989: Tsao M; Ferrarini M; Evans C; Ambro A; Whiteside T L
Purification of a glycosaminoglycan-stimulatory lymphokine from supernatants of in vitro-activated human mononuclear cells.
Clinical immunology and immunopathology 1989;50(1 Pt 1):122-31.
1989: Melder R J; Rosenfeld C S; Herberman R B; Whiteside T L
Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man.
Cancer immunology, immunotherapy : CII 1989;29(1):67-73.
1989: Whiteside T L; Buckingham R B
Interactions between cells of the immune system and hyaluronate synthesis by human dermal fibroblasts.
Ciba Foundation symposium 1989;143():170-81; discussion 182-6, 281-5.
1989: Whiteside T L; Heo D S; Takagi S; Herberman R B
Tumor-infiltrating lymphocytes from human solid tumors: antigen-specific killer T lymphocytes of activated natural killer lymphocytes.
Immunology series 1989;48():139-57.
1988: Whiteside T L; Wang Y L; Selker R G; Herberman R B
In vitro generation and antitumor activity of adherent lymphokine-activated killer cells from the blood of patients with brain tumors.
Cancer research 1988;48(21):6069-75.
1988: Whiteside T L; Ferrarini M; Hebda P; Buckingham R B
Heterogeneous synthetic phenotype of cloned scleroderma fibroblasts may be due to aberrant regulation in the synthesis of connective tissues.
Arthritis and rheumatism 1988;31(10):1221-9.
1988: Melder R J; Whiteside T L; Vujanovic N L; Hiserodt J C; Herberman R B
A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
Cancer research 1988;48(12):3461-9.
1988: Whiteside T L; Miescher S; Moretta L; von Fliedner V
Cloning and proliferating precursor frequencies of tumor-infiltrating lymphocytes from human solid tumors.
Transplantation proceedings 1988;20(2):342-3.
1988: Whiteside T L; Heo D S; Takagi S; Herberman R B
Characterization of novel anti-tumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes.
Transplantation proceedings 1988;20(2):347-50.
1988: Adler A; Chervenick P A; Whiteside T L; Lotzová E; Herberman R B
Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission.
Blood 1988;71(3):709-16.
1988: Whiteside T L; Heo D S; Takagi S; Johnson J T; Iwatsuki S; Herberman R B
Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2.
Cancer immunology, immunotherapy : CII 1988;26(1):1-10.
1987: Heo D S; Whiteside T L; Johnson J T; Chen K N; Barnes E L; Herberman R B
Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
Cancer research 1987;47(23):6353-62.
1987: Whiteside T L; Heo D S; Chen K; Adler A; Johnson J T; Herberman R B
Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Progress in clinical and biological research 1987;244():213-22.
1982: Penchansky L; Whiteside T L; Wollman M R; Albo V C
Sex differences in prognosis of childhood T-cell leukemia.
Medical and pediatric oncology 1982;10(4):339-48.
1981: Penchansky L; Whiteside T; Wollman M; Malatack J
Philadelphia chromosome--positive pre-B-lymphocytic leukemia in a child.
The American journal of pediatric hematology/oncology 1981;3(3):265-8.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Theresa Whiteside

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Physiology

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Theresa Whiteside (preview)

All Publications